TAMESHA KAMCONTEH: Open Payments
NPI 1871138412 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$270 in 10 payments from 9 companies in 2025. Trend: 2023 $650 · 2024 $305 · 2025 $270
Food & beverage: $270
| Company | Payments | Amount |
|---|---|---|
| Medtronic, Inc. | 2 | $47 |
| Merck Sharp & Dohme LLC | 1 | $34 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $33 |
| Syndax Pharmaceuticals, Inc. | 1 | $31 |
| Incyte Corporation | 1 | $28 |
| pharmaand GmbH | 1 | $27 |
| TOLMAR, INC. | 1 | $27 |
| Gamida Cell Inc. | 1 | $25 |
| Collegium Pharmaceutical, Inc. | 1 | $20 |
Products named: INCEPTIV, PREVYMIS, LIVTENCITY, JAKAFI, Rubraca, ELIGARD, OMISIRGE, Belbuca.
Industry payments across TX — which companies pay providers there.
